Rapid Micro Biosystems, Inc. (RPID) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

18/25

Growth 5 Margin 2 Expansion 5 Platform 4 Financial 2

latest quarter score

Earnings Reports

18
RPID Q2 2026: 14% Recurring Revenue Growth Highlights Strengthening Platform Adoption
August 08, 2026
18
Rapid Microbiosystems (RPID) Q1 2026: Consumables Surge 30%, Margin Inflection Anchors FY Trajectory
May 14, 2026
18
Rapid Microbiosystems (RPID) Q4 2025: 78% Product Revenue Surge Anchors System Placement Momentum
March 12, 2026
15
Rapid Microbiosystems (RPID) Q3 2025: Double-Digit Multi-System Order Expands Global Biopharma Penetration
November 07, 2025
15
Rapid Microbiosystems (RPID) Q2 2025: Recurring Revenue Climbs 15%, Margin Expansion Accelerates on Cost Initiatives
August 12, 2025
20
Rapid Micro Biosystems (RPID) Q1 2025: 28% Revenue Growth and 33-Point Gross Margin Expansion Signal Operational Leverage
May 09, 2025
Rapid Microbiosystems (RPID) Q4 2024: Gross Margin Turns Positive, Millipore Sigma Partnership Sets Up 2026 Step-Change
February 28, 2024

Browse all companies